Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-01-10
2008-08-12
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S327000
Reexamination Certificate
active
07410949
ABSTRACT:
Provided herein are neuropeptide-2 receptor agonists of the formula (I):in-line-formulae description="In-line Formulae" end="lead"?Y—R1—R2—X—R3—R4—R5—R6—R7—R8—R9—R10—R11—R12—R13—R14—NH2, (I)in-line-formulae description="In-line Formulae" end="tail"?as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity.
REFERENCES:
patent: 5283317 (1994-02-01), Saifer et al.
patent: 5468478 (1995-11-01), Saifer et al.
patent: WO 94/22467 (1994-10-01), None
patent: WO 2005/080242 (2005-09-01), None
Poter, E.K., et. al. Eur. J. Pharmac. 267, 253-262 (1994).
Bloom, S., et. al., Nature vol. 418, Aug. 8, 2002, p. 650-654.
Krstenansky, et. al. in Peptides, Proceedings of the Twelfth American Peptide Symposium., J. Smith and J. Rivier Editors, ESCOM. Leiden p. 136-137 (not dated).
Somack, R., et. al. (1991) Free Rad Res Commun 12-13:553-562.
Saifer, MGP, et. al. (1997) Polym Preprints 38:576-577.
Sherman, M. R., et. al. (1997) in J M Harris, et. al., (Eds.), Poly(ethylene glycol) Chemistry and Biological Applications. ACS Symposium Series 680 p. 155-169, Washington, DC: American Chemical Society.
Bloom, S., et. al., New England J. of Med. (2003) 349, 941-948.
Balasubramaniam, et. al., J. Med. Chem. (2000) 43, 3420-3427.
G. Beck-Sickinger, et. al., Regulatory peptides 75-76 (10998) p. 3-8.
A.G. Beck-Sickinger, et. al., FEBS Letters 394 (1996) 169-173.
G. Jung, et. al., Eur. J. Biochem. 225, (1994), p. 947-958.
A.G. Beck-Sickinger, et. al. Biopolymers (Peptide Science) vol. 27, p. 123-142 (1995).
J. R. Reeve, Jr., et. al., Biochemistry 2000, p. 9935-9942.
Beck-Sickinger, A.G., et al., European Journal Of Biochemistry, vol. 206, No. 3, pp. 957-964 (1992).
Beck A., et al., FEBS Letters, vol. 244, No. 1, pp. 119-122 (1989).
Beck-Sickinger, A.G., et al., European Journal of Biochemistry, vol. 194, No. 2, pp. 449-456 (1990).
Krstenansky, J.L., et al., Proceedings of the National Academy of Sciences of the United States of America, vol. 86, No. 12, pp. 4377-4381 (1989).
Boggiano, M.M., et al., Obesity Reviews, vol. 6, No. 4, pp. 307-322 (2005).
Danho Waleed
Ehrlich George
Fry David C
Khan Wajiha
Swistok Joseph
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Russel Jeffrey E
Tramaloni Dennis P.
LandOfFree
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuropeptide-2 receptor (Y-2R) agonists and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuropeptide-2 receptor (Y-2R) agonists and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3996586